The Pennant Group (NASDAQ:PNTG) Price Target Increased to $38.00 by Analysts at Truist Financial

The Pennant Group (NASDAQ:PNTG) had its price objective lifted by Truist Financial from $34.00 to $38.00 in a report published on Monday morning, Benzinga reports. Truist Financial currently has a hold rating on the stock.

Several other research analysts also recently weighed in on the company. Oppenheimer boosted their price target on The Pennant Group from $28.00 to $34.00 and gave the company an outperform rating in a report on Thursday, August 8th. Stephens lifted their price objective on The Pennant Group from $28.00 to $32.00 and gave the company an overweight rating in a research report on Thursday, August 8th.

The Pennant Group Price Performance

Shares of NASDAQ PNTG opened at $32.92 on Monday. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 0.48. The company’s 50-day moving average price is $32.88 and its 200 day moving average price is $26.45. The Pennant Group has a 52 week low of $10.31 and a 52 week high of $37.13. The stock has a market cap of $989.11 million, a price-to-earnings ratio of 60.96, a PEG ratio of 3.33 and a beta of 2.01.

The Pennant Group (NASDAQ:PNTG) last released its quarterly earnings results on Tuesday, August 6th. The company reported $0.19 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.02. The company had revenue of $168.75 million during the quarter, compared to the consensus estimate of $156.71 million. The Pennant Group had a return on equity of 13.74% and a net margin of 3.16%. As a group, research analysts forecast that The Pennant Group will post 0.75 earnings per share for the current fiscal year.

Hedge Funds Weigh In On The Pennant Group

Several hedge funds and other institutional investors have recently made changes to their positions in PNTG. Creative Planning lifted its stake in shares of The Pennant Group by 2.0% during the second quarter. Creative Planning now owns 19,152 shares of the company’s stock worth $444,000 after purchasing an additional 373 shares in the last quarter. The Manufacturers Life Insurance Company raised its holdings in shares of The Pennant Group by 4.4% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 11,227 shares of the company’s stock valued at $260,000 after buying an additional 471 shares during the period. Principal Financial Group Inc. lifted its position in The Pennant Group by 9.9% during the 2nd quarter. Principal Financial Group Inc. now owns 11,029 shares of the company’s stock worth $256,000 after acquiring an additional 991 shares in the last quarter. Covestor Ltd boosted its holdings in The Pennant Group by 3,805.6% in the 1st quarter. Covestor Ltd now owns 1,406 shares of the company’s stock worth $28,000 after acquiring an additional 1,370 shares during the period. Finally, Oppenheimer Asset Management Inc. boosted its holdings in The Pennant Group by 17.1% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 17,486 shares of the company’s stock worth $406,000 after acquiring an additional 2,549 shares during the period. Institutional investors and hedge funds own 85.88% of the company’s stock.

About The Pennant Group

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.